Neurable
Founded Year
2016Stage
Unattributed VC | AliveTotal Raised
$9.58MAbout Neurable
Neurable develops brain-computer interface (BCI) technology that uses Electroencephalogram (EEG) activity and builds an intelligent layer between the brain and computers. Powered by a signal processing, the Neurable Brain OS platform enables high performance brain-computer interfaces in everyday devices. It focuses on building hardware and devices to measure brain activity and provide actionable insights. The company was founded in 2016 and is based in Boston, Massachusetts. .
Missing: Neurable's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Neurable's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Neurable
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Neurable in 1 CB Insights research brief, most recently on Mar 30, 2022.
Expert Collections containing Neurable
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Neurable is included in 1 Expert Collection, including AR/VR.
AR/VR
1,397 items
This collection includes companies creating hardware and/or software for augmented reality, virtual reality, and mixed reality applications.
Neurable Patents
Neurable has filed 8 patents.
The 3 most popular patent topics include:
- Assistive technology
- Neurophysiology
- Neuroscience
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/15/2020 | 3/21/2023 | Artificial neural networks, Biometrics, Artificial intelligence, Machine learning, Theory of mind | Grant |
Application Date | 12/15/2020 |
|---|---|
Grant Date | 3/21/2023 |
Title | |
Related Topics | Artificial neural networks, Biometrics, Artificial intelligence, Machine learning, Theory of mind |
Status | Grant |
Latest Neurable News
May 25, 2023
Neurable Enables Reliable Everyday Brain-Computer Interfaces To Exist In Everyday Products Q: Could you provide our readers with a brief introduction to your company? A: Neurable is building an intelligent layer between the brain and computers. Using our patented BrainOS AI we enable reliable everyday brain-computer interfaces to exist in everyday products. Powered by patented signal processing, developed through 10+ years of research at the University of Michigan, the Neurable Brain OS platform enables high performance brain-computer interfaces in everyday devices. We license our technology to allow companies to capitalize on wearable brain-computer interface technology and provide customers with insights on their mental health, productivity, and hands/voice free control of their wearable audio device. Our strategy reinforces a flywheel effect whereby we can ethically leverage data from our users to create never before possible BCI capabilities. Q: Any highlights on your recent announcement? A: Epson is a leading maker of Augmented Reality. Their investment in Neurable is a strong sign for future technologies and products that stand to benefit from brain-computer interface technologies. Q: Can you give us more insights into your offering? A: Similar to how various wearable products such as Garmin, Apple Watch, Oura, and others give physiological based insights to improve health and performance, we enable a new class of wearables (or hearables) that make sense of biopotentials from the brain, heart, eyes, and more to improve cognition, health, and performance. Neurable already has biomarkers and features based on them covering attention estimates, distractions, fatigue, and more! Q: What can we expect from your company in next 6 months? What are your plans? A: Unfortunately, we can’t say exactly but it would be safe to expect something very exciting in the next six months, stay tuned!
Neurable Frequently Asked Questions (FAQ)
When was Neurable founded?
Neurable was founded in 2016.
Where is Neurable's headquarters?
Neurable's headquarters is located at 45 Bromfield St, Boston.
What is Neurable's latest funding round?
Neurable's latest funding round is Unattributed VC.
How much did Neurable raise?
Neurable raised a total of $9.58M.
Who are the investors of Neurable?
Investors of Neurable include Seiko Epson, Epson X Investment, Global Brain, TRAC, Paycheck Protection Program and 14 more.
Who are Neurable's competitors?
Competitors of Neurable include NextMind and 3 more.
Compare Neurable to Competitors
Paradromics provides high data-rate brain-computer interfaces (BCI). It enables better treatment options for neurodegenerative diseases and advanced neuroprosthetic limbs for those suffering from amputation and spinal cord injuries. The company was founded in 2015 and is based in Austin, Texas.
Neuralink develops brain-machine interfaces (BMIs) ultra-high bandwidth brain-machine interfaces to connect humans and computers to create devices that can be implanted into the human brain to enable an interface between the human brain and computers or other external devices. It helps people with paralysis. Its interface helps in treating and diagnosing neurological issues. The company was founded in 2016 and is based in Fremont, California.
Synchron is a medical device company focusing on the development of minimally invasive neuromodulation technology solutions. It develops an endovascular brain-computer interface that can access every corner of the brain using the blood vessels. It offers Synchron’s switch device to help paralyzed people, such as those with amyotrophic lateral sclerosis (ALS), communicate by controlling computer cursors with their minds. The company was founded in 2016 and is based in Brooklyn, New York.
Blackrock Neurotech’s mission is to provide tools and neurotech expertise to translate technology into implantable clinical solutions that improve human lives. Blackrock’s precision electrode technology is at the core of many worldwide innovations in Brain-Computer Interfaces (BCI), and through neural signal processing and stimulation, it has enabled BCI Pioneers to walk, talk, see, hear, and feel again.
IDUN Technologies operates as a medical device firm. It develops and produces soft and dry conductive electrodes for biopotential monitoring. Its surface structure allows these electrodes to provide signals with skin-friendly materials without electrolyte gel or glue. The company was founded in 2017 and is based in Glattpark, Switzerland.
Kernel is a human intelligence company. It develops brain-based biomarkers to develop new treatments, improve patient care, and optimize brain function. It was founded in 2016 and is based in Culver City, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.